Home > Newsletters > FDAnews Drug Daily Bulletin > GenPath Pharmaceuticals Becomes AVEO Pharmaceuticals
FDAnews Drug Daily Bulletin
March 2, 2005 | Vol. 2 No. 43
GenPath Pharmaceuticals Becomes AVEO Pharmaceuticals
GenPath Pharmaceuticals, a drug discovery and development company focused on the treatment of cancer and other diseases, announced that it has changed its corporate name to AVEO Pharmaceuticals. "The name change, together with the recent relocation to our new and expanded facility, marks the next phase of growth for our company," said Tuan Ha-Ngoc, president and CEO of AVEO Pharmaceuticals.
Yahoo News (http://biz.yahoo.com/bw/050301/15149_1.html)
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.